AceView: Gene:USP40, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.

cDNA accession Links to the sequence	Tissue most 5' clones in red	Match mRNA	From bp to bp in mRNA	From bp to bp in accs.	Clone encodes complete protein (with AA variation)	Features	Anomalies detected by AceView	Accession match over (% length)	Base differences relative to genome (% identity)
AJ583821		.a	1 to 3744	1 to 3744	exact	tiling clone,		3744/3744 (100 %)	1 diff (100.0 %id)
NM_018218.2		.a	1 to 5623	1 to 5623	exact	RefSeq,		5623/5623 (100 %)	6 diff (99.9 %id)
AK001647		.a	39 to 3462	1 to 3424		available from FLJ,		3424/3424 (100 %)	1 diff (100.0 %id)
AU132741		.a	40 to 880	2 to 844		capped		843/873 (96 %)	13 diff (98.6 %id)
DA104934	cerebellum	.a	103 to 681	2 to 580		capped		579/579 (100 %)	1 diff (99.9 %id)
BF804934	colon_ins	.a	150 to 418	271 to 3			Submitted on the opposite strand	269/297 (90 %)	0 diff (100 %id)
FN076673	breast carcinoma	.a	445 to 551	1 to 111				111/111 (100 %)	3 diff (97.3 %id)
AW752890	colon	.a	1341 to 1840	500 to 1				500/500 (100 %)	4 diff (99.2 %id)
AW752888	colon	.a	1358 to 1840	483 to 1				483/483 (100 %)	1 diff (99.8 %id)
BE883410	leiomyosarcoma, uterus	.a	1397 to 1718	1 to 327				327/810 (40 %)	8 diff (99.1 %id)
BF371578	prostate_normal	.a	1413 to 1945	549 to 17				533/549 (97 %)	0 diff (100 %id)
DA449427	tongue, tumor tissue	.a	1475 to 2037	2 to 564		capped		563/563 (100 %)	0 diff (100 %id)
BG749384	eye, normal pigmented retinal epithelium	.a	1480 to 2152	1 to 687				687/810 (84 %)	18 diff (97.8 %id)
DA895178	skeletal muscle	.a	1762 to 2312	2 to 555		capped		551/554 (99 %)	3 diff (99.5 %id)
AW855481	colon	.a	1891 to 2018	14 to 141				128/156 (82 %)	8 diff (94.9 %id)
DN998017	breast cancer, Mammary gland (cancer tissue)	.a	2009 to 2592	1 to 584				584/584 (100 %)	5 diff (99.2 %id)
BE295075	muscle, rhabdomyosarcoma	.a	2248 to 2907	1 to 661				661/738 (89 %)	14 diff (98.2 %id)
CB267727	adipose	.a	2346 to 2891	1 to 545				545/545 (100 %)	3 diff (99.5 %id)
AK295569	hippocampus	.a	2429 to 3094	1 to 665				665/1298 (51 %)	2 diff (99.9 %id)
DC331748	hippocampus	.a	2429 to 2987	1 to 558				558/558 (100 %)	1 diff (99.9 %id)
BF736811	bladder_tumor	.a	2542 to 2953	415 to 6			Submitted on the opposite strand	410/415 (98 %)	7 diff (98.4 %id)
AI214561	carcinoid, lung	.a	2582 to 2912	1 to 331			Submitted on the opposite strand	331/331 (100 %)	4 diff (98.8 %id)
BF326332	amnion_normal	.a	2627 to 2900	1 to 274				274/284 (96 %)	1 diff (99.7 %id)
BU076627	Pancreas, Purified pancreatic islet	.a	2707 to 3261	1 to 555		fully sequenced,		555/555 (100 %)	0 diff (100 %id)
BM553538	duodenal adenocarcinoma, cell line, small intestine	.a	2756 to 3537	1 to 784				784/1000 (78 %)	11 diff (98.9 %id)
BF514374		.a	2799 to 3267	18 to 486			Submitted on the opposite strand	469/469 (100 %)	0 diff (100 %id)
TI_57191083		.a	2807 to 3470	55 to 720				666/668 (99 %)	4 diff (99.5 %id)
BI857819	breast, mammary adenocarcinoma, cell line	.a	2808 to 3470	1 to 665				665/667 (99 %)	4 diff (99.5 %id)
BQ712449	Spleen	.a	2869 to 3782	1 to 917				917/917 (100 %)	19 diff (98.0 %id)
BQ708713	Spleen	.a	2870 to 3417	18 to 569				552/794 (69 %)	19 diff (97.7 %id)
BM914346	Spleen	.a	2872 to 3430	1 to 560				560/1090 (51 %)	7 diff (99.4 %id)
BQ709160	Spleen	.a	2872 to 3732	1 to 869				869/927 (93 %)	15 diff (98.4 %id)
BF799756	colon_ins	.a	2893 to 3209	27 to 343				317/343 (92 %)	6 diff (98.3 %id)
AU154214		.a	2934 to 3462	530 to 1				530/530 (100 %)	1 diff (99.9 %id)
AA583968	larynx	.a	2996 to 3432	437 to 1				437/437 (100 %)	1 diff (99.8 %id)
AI023835		.a	3010 to 3466	457 to 1				457/457 (100 %)	0 diff (100 %id)
AI276469	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.a	3047 to 3456	410 to 1				410/410 (100 %)	1 diff (99.8 %id)
AW338435	adenocarcinoma, Pancreas	.a	3069 to 3462	394 to 1				394/394 (100 %)	0 diff (100 %id)
AI061230		.a	3076 to 3464	389 to 1				389/389 (100 %)	0 diff (100 %id)
AI149794		.a	3082 to 3441	402 to 43		AAA		360/380 (94 %)	3 diff (99.3 %id)
BX099887	pooled germ cell tumors	.a	3097 to 3467	380 to 10		AAA	Internal priming: the 3' end of the oligo dT primed clone lies in the CDS	371/427 (86 %)	3 diff (99.3 %id)
AW450321		.a	3117 to 3441	362 to 38		AAA		325/351 (92 %)	22 diff (93.8 %id)
EC449371	Prostate	.a	3138 to 3231	1 to 94				94/113 (83 %)	3 diff (97.4 %id)
EC477668	Prostate	.a	3138 to 3247	1 to 109				109/109 (100 %)	2 diff (98.2 %id)
AI970912	Prostate	.a	3154 to 3461	308 to 1				308/308 (100 %)	0 diff (100 %id)
BF972070	leiomyosarcoma cell line, uterus	.a	3170 to 3830	15 to 678				664/1310 (50 %)	21 diff (98.4 %id)
BG338717	leiomyosarcoma cell line, uterus	.a	3170 to 3967	15 to 799				785/799 (98 %)	34 diff (95.8 %id)
BU076346	Pancreas, Purified pancreatic islet	.a	3200 to 3461	262 to 1		fully sequenced,		262/262 (100 %)	3 diff (98.9 %id)
AA679592		.a	3321 to 3475	158 to 4				155/158 (98 %)	1 diff (99.4 %id)
BC013305	Muscle, rhabdomyosarcoma	.a	3516 to 5609	1 to 2094		tiling clone, available from MGC, AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	2094/2094 (100 %)	0 diff (100 %id)
BE300339	muscle, rhabdomyosarcoma	.a	3516 to 4312	24 to 821		available from MGC,		798/827 (96 %)	13 diff (98.5 %id)
BF205107	muscle, rhabdomyosarcoma	.a	3529 to 4280	1 to 744				744/765 (97 %)	14 diff (98.2 %id)
AK295112	brain	.b	1 to 1114	1 to 1116		tiling clone,		1116/1116 (100 %)	3 diff (99.8 %id)
DA462210	tongue, tumor tissue	.b	2 to 491	2 to 491		capped		490/490 (100 %)	1 diff (99.8 %id)
DB000895	breast, tumor tissue	.b	18 to 553	2 to 537		capped		536/536 (100 %)	1 diff (99.9 %id)
DA449527	tongue, tumor tissue	.b	20 to 583	2 to 565		capped		564/564 (100 %)	3 diff (99.5 %id)
DA887274		.b	20 to 568	2 to 550		capped		549/549 (100 %)	0 diff (100 %id)
CD359558	testis	.b	22 to 813	1 to 800		available from MGC,		800/878 (91 %)	10 diff (98.9 %id)
DA725190		.b	25 to 591	2 to 568		capped		567/567 (100 %)	1 diff (99.9 %id)
DA754253		.b	25 to 590	2 to 567		capped		566/566 (100 %)	1 diff (99.9 %id)
DB081859	testis	.b	25 to 571	2 to 548		capped		547/547 (100 %)	0 diff (100 %id)
DA034433		.b	26 to 554	2 to 530		capped		529/529 (100 %)	1 diff (99.9 %id)
DA861813	placenta	.b	26 to 586	2 to 562		capped		561/561 (100 %)	0 diff (100 %id)
DB213313	trachea	.b	26 to 570	2 to 546		capped		545/545 (100 %)	0 diff (100 %id)
DB223978	trachea	.b	26 to 585	2 to 561		capped		560/560 (100 %)	0 diff (100 %id)
DB291159	uterus	.b	26 to 596	2 to 572		capped		571/571 (100 %)	0 diff (100 %id)
CN286175	embryonic stem cells, cell lines H1, H7, andH9	.b	36 to 701	1 to 665				665/665 (100 %)	6 diff (99.1 %id)
BE784232	eye, retinoblastoma	.b	579 to 1252	1 to 673				673/988 (68 %)	13 diff (98.7 %id)
DA591768	lung	.b	947 to 1510	2 to 566		tiling clone, capped		565/565 (100 %)	3 diff (99.5 %id)
DC356432	heart	.b	998 to 1544	1 to 548		tiling clone,		548/548 (100 %)	4 diff (99.3 %id)
DA499080	brain	.b	1092 to 1646	2 to 556		tiling clone, capped		555/555 (100 %)	1 diff (99.9 %id)
DC362993	Liver	.c	1 to 641	1 to 641		tiling clone,		641/641 (100 %)	1 diff (99.9 %id)
CR624131	Neuroblastoma Cot 25-normalized	.c	364 to 1410	1 to 1047		tiling clone,		1047/1047 (100 %)	0 diff (100 %id)
BX374741	Neuroblastoma Cot 25-normalized	.c	364 to 1393	1 to 1023				1023/1023 (100 %)	24 diff (97.7 %id)
BX350821	Neuroblastoma Cot 25-normalized	.c	541 to 1404	871 to 1				868/871 (99 %)	15 diff (98.3 %id)
BU618998	Cell Line, Chondrosarcoma	.c	690 to 1403	729 to 17		AAA		713/714 (99 %)	1 diff (99.9 %id)
BX369719	Neuroblastoma Cot 25-normalized	.c	1084 to 1410	1 to 330				330/330 (100 %)	5 diff (98.5 %id)
DA493776	brain	.c	1184 to 1702	2 to 521		tiling clone, capped		520/520 (100 %)	1 diff (99.9 %id)
DB315538	brain	.c	2474 to 2980	508 to 1		tiling clone,		508/508 (100 %)	7 diff (98.7 %id)
DA570234	whole embryo, mainly head	.d	1 to 726	2 to 725		tiling clone, capped		724/724 (100 %)	5 diff (99.4 %id)
BF994426	placenta_normal	.d	18 to 350	1 to 332				332/351 (94 %)	7 diff (98.1 %id)
DB356986	whole embryo, mainly head	.d	982 to 1577	592 to 1	T2P	tiling clone,		592/593 (99 %)	15 diff (97.5 %id)
AL833371	lymph node	.e	1 to 2721	1 to 2721	exact	tiling clone, available from DKFZ, AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	2721/2721 (100 %)	0 diff (100 %id)
H73443	liver and spleen	.e	1740 to 2181	1 to 455				455/465 (97 %)	20 diff (95.7 %id)
H74202	liver and spleen	.e	2377 to 2729	363 to 8				356/442 (80 %)	0 diff (100 %id)
DR002802	fetal brain	.f	1 to 631	2 to 632	exact	tiling clone,		632/632 (100 %)	3 diff (99.6 %id)
DA445985	tongue, tumor tissue	.g	1 to 571	2 to 572		tiling clone, capped		571/571 (100 %)	1 diff (99.9 %id)
DB074701	testis	.g	50 to 569	2 to 521		capped		520/520 (100 %)	1 diff (99.9 %id)
AL712528	human skeletal muscle	.g	51 to 610	1 to 560				560/560 (100 %)	5 diff (99.2 %id)
DA220534	brain	.g	55 to 614	2 to 561		capped		560/560 (100 %)	1 diff (99.9 %id)
DA458065	tongue, tumor tissue	.g	55 to 638	2 to 585		capped		584/584 (100 %)	1 diff (99.9 %id)
BI598364	brain, hypothalamus	.g	56 to 828	1 to 767	K173T E174R C175M K176L N177E ...	tiling clone,		767/941 (81 %)	25 diff (97.4 %id)
DB084951	testis	.g	56 to 611	2 to 557		capped		556/556 (100 %)	0 diff (100 %id)
DB196353	trachea	.g	56 to 499	2 to 445		capped		444/449 (98 %)	1 diff (99.8 %id)
DA246623	brain	.g	57 to 639	2 to 585		capped		584/584 (100 %)	2 diff (99.7 %id)
DA461466	tongue, tumor tissue	.g	57 to 646	2 to 591		capped		590/590 (100 %)	1 diff (99.9 %id)
DA655020		.g	57 to 628	2 to 573		capped		572/572 (100 %)	0 diff (100 %id)
DA740864		.g	59 to 576	2 to 519		capped		518/518 (100 %)	0 diff (100 %id)
DB221082	trachea	.g	59 to 602	2 to 545		capped		544/544 (100 %)	0 diff (100 %id)
DC324629	brain	.g	61 to 648	1 to 588				588/588 (100 %)	1 diff (99.9 %id)
AL603268	human skeletal muscle	.g	61 to 651	1 to 591				591/591 (100 %)	3 diff (99.5 %id)
TI_45214856		.g	61 to 828	92 to 853	K173T E174R C175M K176L N177E ...			762/1027 (74 %)	25 diff (97.6 %id)
DA723719		.g	61 to 620	2 to 561		capped		560/560 (100 %)	1 diff (99.9 %id)
DA459366	tongue, tumor tissue	.g	62 to 632	2 to 572		tiling clone, capped		571/571 (100 %)	0 diff (100 %id)
DA724596		.g	62 to 617	2 to 557		capped		556/556 (100 %)	1 diff (99.9 %id)
DA864858	placenta	.g	62 to 616	2 to 556		capped		555/555 (100 %)	1 diff (99.9 %id)
DA865030	placenta	.g	62 to 631	2 to 571		capped		570/570 (100 %)	0 diff (100 %id)
DB005657	breast, tumor tissue	.g	62 to 641	2 to 582		capped		581/581 (100 %)	2 diff (99.7 %id)
DB232903	trachea	.g	62 to 657	2 to 597		capped		596/596 (100 %)	1 diff (99.9 %id)
DA451532	tongue, tumor tissue	.g	63 to 626	2 to 565		capped		564/564 (100 %)	2 diff (99.7 %id)
DB223270	trachea	.g	63 to 638	2 to 580		capped		579/579 (100 %)	3 diff (99.5 %id)
DB237757	trachea	.g	64 to 644	2 to 582		capped		581/581 (100 %)	1 diff (99.9 %id)
DA715732		.g	66 to 610	2 to 546		capped		545/545 (100 %)	0 diff (100 %id)
DB078567	testis	.g	66 to 619	2 to 555		capped		554/554 (100 %)	0 diff (100 %id)
DA415259	thalamus	.g	67 to 617	2 to 552		capped		551/551 (100 %)	0 diff (100 %id)
DA453405	tongue, tumor tissue	.g	69 to 628	2 to 561		capped		560/560 (100 %)	1 diff (99.9 %id)
DA712077		.g	70 to 647	2 to 580		capped		579/579 (100 %)	2 diff (99.7 %id)
DA457163	tongue, tumor tissue	.g	71 to 644	2 to 575		capped		574/574 (100 %)	1 diff (99.9 %id)
TI_57146475		.g	71 to 663	33 to 628				596/905 (65 %)	9 diff (99.1 %id)
DA988961	synovial membrane tissue from rheumatioidarthritis	.g	71 to 640	2 to 571		capped		570/570 (100 %)	1 diff (99.9 %id)
AA127740	uterus	.h	1 to 619	612 to 1		tiling clone,		612/627 (97 %)	16 diff (97.5 %id)
CN482400	eye	.h	27 to 665	1 to 639		tiling clone,		639/639 (100 %)	0 diff (100 %id)
BE784846	large cell carcinoma, lung	.h	31 to 623	1 to 591				591/591 (100 %)	7 diff (98.9 %id)
BE786821	large cell carcinoma, lung	.h	81 to 795	1 to 713	Q63R D64T V65C L66C L67*	tiling clone,		713/905 (78 %)	43 diff (95.3 %id)
CR979954	T-Lymphocytes	.i	1 to 670	1 to 669	Q150X G163E D164I T165L	tiling clone,		669/671 (99 %)	3 diff (99.6 %id)
AK124094	esophageal, tumor tissue	.j	1 to 1945	2 to 1946	exact	tiling clone, available from FLJ,		1946/1946 (100 %)	0 diff (100 %id)
DB017189	esophageal, tumor tissue	.j	1 to 574	2 to 575		capped		574/574 (100 %)	0 diff (100 %id)
DA948684	Spleen	.j	454 to 1011	2 to 559		capped		558/558 (100 %)	1 diff (99.9 %id)
DB335487	esophageal, tumor tissue	.j	1414 to 1945	533 to 1				533/533 (100 %)	1 diff (99.9 %id)
CB958567	Pooled-Glandular	.j	1478 to 2208	1 to 736		tiling clone,		736/737 (99 %)	7 diff (99.1 %id)
BX096463	pooled	.j	1483 to 1943	1 to 460		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	460/460 (100 %)	2 diff (99.6 %id)
AA917073	pooled	.j	1635 to 1947	313 to 1				313/313 (100 %)	3 diff (99.1 %id)
DA456016	tongue, tumor tissue	.k	-8 to 559	2 to 569	E127V	tiling clone, capped		568/568 (100 %)	2 diff (99.7 %id)
CD655892	Embryonic Stem cells	.l	1 to 800	5 to 807	G2P T66A L85A Y86P L88S ...	tiling clone,		803/807 (99 %)	15 diff (98.2 %id)
BM701644	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.m	1 to 299	1 to 299		tiling clone, fully sequenced,		299/299 (100 %)	0 diff (100 %id)
BU738706	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.m	238 to 625	406 to 19		tiling clone, fully sequenced, AAA		388/388 (100 %)	1 diff (99.8 %id)
BM704491	eye, Retina Foveal and Macular	.n	1 to 348	1 to 348	Q115K	tiling clone, fully sequenced,		348/348 (100 %)	3 diff (99.2 %id)
BU736662	eye, Retina Foveal and Macular	.n	67 to 347	282 to 1		fully sequenced,		282/282 (100 %)	3 diff (99.0 %id)
AW863694	stomach_normal	.o	1 to 431	430 to 2		tiling clone,		429/434 (98 %)	0 diff (100 %id)
BE645412	Prostate	.o	291 to 634	344 to 1	exact	tiling clone,		344/344 (100 %)	0 diff (100 %id)
AI921324	adenocarcinoma, Pancreas	.p	1 to 453	460 to 8	exact	tiling clone,		453/460 (98 %)	0 diff (100 %id)
DA715916		.q-u	1 to 538	2 to 539		tiling clone, capped		538/538 (100 %)	1 diff (99.9 %id)
AA377983	synovial membrane	.q-u	359 to 621	1 to 263		tiling clone,		263/263 (100 %)	0 diff (100 %id)
AL120598	amygdala	.q-u	1350 to 1889	1 to 541		tiling clone,		541/541 (100 %)	2 diff (99.7 %id)
CF265115	Brain glioblastoma	.q-u	1473 to 2059	1 to 589				589/784 (75 %)	12 diff (98.5 %id)
BE145775	head_neck	.q-u	1633 to 1835	1 to 203				203/203 (100 %)	1 diff (99.6 %id)
BG326507	Kidney, renal cell adenocarcinoma	.q-u	1649 to 2191	120 to 661				542/662 (81 %)	5 diff (99.3 %id)
BY795322	eye	.q-u	1663 to 2248	1 to 586				586/586 (100 %)	0 diff (100 %id)
BP425888	small intestine	.q-u	1684 to 2040	360 to 1				360/360 (100 %)	5 diff (98.7 %id)
CV574568	cornea, eye	.q-u	1686 to 2057	1 to 372				372/372 (100 %)	2 diff (99.5 %id)
BG489962	large cell carcinoma, lung	.q-u	1724 to 2386	1 to 663				663/663 (100 %)	0 diff (100 %id)
FN057606	breast carcinoma	.q-u	1734 to 1819	86 to 1			Submitted on the opposite strand	86/88 (97 %)	0 diff (100 %id)
CR594906	Neuroblastoma Cot 25-normalized	.q-u	1795 to 3270	1 to 1476		tiling clone,		1476/1476 (100 %)	0 diff (100 %id)
BX331970	Neuroblastoma Cot 25-normalized	.q-u	1795 to 2656	1 to 861				861/861 (100 %)	16 diff (98.2 %id)
BM682382	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.q-u	1864 to 2511	1 to 647			Submitted on the opposite strand	647/647 (100 %)	3 diff (99.6 %id)
BQ001269	lung, Metastatic Chondrosarcoma	.q-u	1865 to 2602	1 to 738			Submitted on the opposite strand	738/740 (99 %)	7 diff (99.1 %id)
BC047714	Testis, embryonal carcinoma	.q-u	1868 to 3456	1622 to 34		available from MGC, AAA	Submitted on the opposite strand	1589/1591 (99 %)	2 diff (99.9 %id)
BQ286147	Pancreas, Purified pancreatic islet	.q-u	1878 to 2404	1 to 527			Submitted on the opposite strand	527/527 (100 %)	1 diff (99.9 %id)
AI681267	carcinoid, lung	.q-u	1882 to 2372	1 to 491			Submitted on the opposite strand	491/491 (100 %)	2 diff (99.6 %id)
AI813470	2 pooled tumors (clear cell type), Kidney	.q-u	1882 to 2288	1 to 406			Submitted on the opposite strand	406/406 (100 %)	3 diff (99.3 %id)
AW002292	thymus, pooled	.q-u	1882 to 2270	1 to 388			Submitted on the opposite strand	388/388 (100 %)	1 diff (99.8 %id)
CB241030	Human Lung Epithelial cells, lung	.q-u	1886 to 2583	713 to 16		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	698/698 (100 %)	2 diff (99.8 %id)
BF304494	muscle, rhabdomyosarcoma	.q-u	1892 to 2562	1 to 663				663/795 (83 %)	7 diff (99.2 %id)
BF304596	muscle, rhabdomyosarcoma	.q-u	1892 to 2615	1 to 724				724/726 (99 %)	12 diff (98.4 %id)
BE297277	muscle, rhabdomyosarcoma	.q-u	1913 to 2454	1 to 542				542/542 (100 %)	0 diff (100 %id)
CK825765	Pancreas, Purified pancreatic islet	.q-u	1941 to 2304	1 to 364				364/364 (100 %)	3 diff (99.2 %id)
DB324162		.q-u	1954 to 2486	533 to 1				533/535 (99 %)	1 diff (99.9 %id)
BG753502	eye, normal pigmented retinal epithelium	.q-u	1973 to 2620	1 to 648				648/648 (100 %)	4 diff (99.4 %id)
BU956432	adenocarcinoma, cell line, breast	.q-u	2065 to 2902	1 to 844				844/877 (96 %)	7 diff (99.3 %id)
CV802683	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.q-u	2081 to 2814	1 to 726				726/829 (87 %)	12 diff (98.6 %id)
BG679666	skin, squamous cell carcinoma	.q-u	2152 to 2999	1 to 844				844/849 (99 %)	7 diff (99.2 %id)
BP432269		.q-u	2172 to 2536	1 to 365				365/365 (100 %)	0 diff (100 %id)
AI818342	adenocarcinoma, Pancreas	.q-u	2244 to 2369	1 to 126			Submitted on the opposite strand	126/126 (100 %)	0 diff (100 %id)
BG824115	adenocarcinoma cell line, colon	.q-u	2254 to 2884	1 to 636				636/638 (99 %)	8 diff (98.8 %id)
AW882372	ovary	.q-u	2272 to 2568	304 to 8				297/313 (94 %)	0 diff (100 %id)
CR993767	T-Lymphocytes	.q-u	2327 to 3165	1 to 839				839/842 (99 %)	3 diff (99.7 %id)
BQ935229	brain, neuroblastoma, cell line	.q-u	2354 to 3285	1 to 937				937/941 (99 %)	27 diff (97.2 %id)
AW392704	stomach	.q-u	2400 to 2955	555 to 1				555/557 (99 %)	8 diff (98.6 %id)
BM844730	lymph node, stomach	.q-u	2469 to 2944	1 to 475				475/475 (100 %)	1 diff (99.8 %id)
BX103809	liver and spleen	.q-u	2475 to 3178	1 to 704				704/704 (100 %)	0 diff (100 %id)
TI_159709882		.q-u	2476 to 3456	1040 to 82		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	959/995 (96 %)	30 diff (97.0 %id)
BX389423	Neuroblastoma Cot 25-normalized	.q-u	2481 to 3265	1 to 792				792/798 (99 %)	15 diff (98.2 %id)
AA382905	testis	.q-u	2493 to 2799	1 to 312				312/316 (98 %)	7 diff (97.8 %id)
AW956738		.q-u	2493 to 3103	1 to 612				612/623 (98 %)	11 diff (98.3 %id)
BM721322	eye, fetal eye	.q-u	2497 to 2991	1 to 495		fully sequenced,	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	495/495 (100 %)	1 diff (99.8 %id)
AA256400	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.q-u	2513 to 2989	1 to 476				476/476 (100 %)	1 diff (99.8 %id)
CB145661	Liver	.q-u	2514 to 2946	1 to 433				433/433 (100 %)	1 diff (99.8 %id)
AA233103	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.q-u	2530 to 2995	1 to 464		fully sequenced,		464/464 (100 %)	4 diff (99.2 %id)
BM693755	eye, lens	.q-u	2534 to 3006	1 to 473		fully sequenced,	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	473/473 (100 %)	0 diff (100 %id)
AA418436	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.q-u	2546 to 3125	1 to 579				579/579 (100 %)	1 diff (99.9 %id)
BX350863	Neuroblastoma Cot 25-normalized	.q-u	2551 to 3452	912 to 1				912/912 (100 %)	48 diff (94.8 %id)
AV692970	hepatocellular carcinoma	.q-u	2552 to 3213	1 to 662				662/670 (98 %)	7 diff (99.0 %id)
AV694056	hepatocellular carcinoma	.q-u	2552 to 3213	1 to 662				662/669 (98 %)	9 diff (98.7 %id)
EL954838	eyeball	.q-u	2553 to 3073	55 to 570				516/570 (90 %)	6 diff (99.0 %id)
H01723	placenta	.q-u	2555 to 2846	1 to 297				297/306 (97 %)	7 diff (97.8 %id)
AW968476		.q-u	2577 to 3086	1 to 510				510/510 (100 %)	9 diff (98.3 %id)
AA459489	germinal center B cell	.q-u	2577 to 3053	1 to 476		fully sequenced,		476/476 (100 %)	1 diff (99.8 %id)
BE745208	adenocarcinoma cell line, ovary	.q-u	2591 to 3253	1 to 666				666/666 (100 %)	7 diff (99.0 %id)
BC086855	Chondrosarcoma, Left Pubic Bone, Lung, chondrosarcoma lung metastasis	.q-u	2607 to 3456	1 to 850		fully sequenced, AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	850/850 (100 %)	1 diff (99.9 %id)
T79712	liver and spleen	.q-u	2609 to 2933	1 to 337				337/370 (91 %)	20 diff (94.6 %id)
CB054286	brain, glioblastoma (pooled)	.q-u	2612 to 2933	3 to 324		fully sequenced,	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	322/324 (99 %)	5 diff (98.5 %id)
BI063184	uterus_tumor	.q-u	2641 to 2914	274 to 1				274/274 (100 %)	2 diff (99.3 %id)
TI_154102167		.q-u	2653 to 3462	877 to 78		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	800/981 (81 %)	17 diff (98.3 %id)
BE840588	prostate_normal	.q-u	2664 to 2942	305 to 29				277/311 (89 %)	0 diff (100 %id)
TI_149285337		.q-u	2670 to 3456	866 to 84		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	783/820 (95 %)	12 diff (98.6 %id)
BF811686	colon_ins	.q-u	2680 to 3041	372 to 11			Submitted on the opposite strand	362/372 (97 %)	0 diff (100 %id)
BE387701	endometrium, adenocarcinoma cell line, uterus	.q-u	2704 to 3359	1 to 650				650/734 (88 %)	9 diff (98.8 %id)
BM693828	eye, lens	.q-u	2714 to 3062	1 to 349		fully sequenced,	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	349/349 (100 %)	2 diff (99.5 %id)
CA428035	Bone, Subchondral Bone	.q-u	2730 to 3456	744 to 19		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	726/726 (100 %)	2 diff (99.8 %id)
BF811401	colon_ins	.q-u	2743 to 3041	328 to 30			Submitted on the opposite strand	299/328 (91 %)	0 diff (100 %id)
CU449532	epidermis	.q-u	2751 to 3036	19 to 305				287/307 (93 %)	10 diff (96.8 %id)
CU450705	epidermis	.q-u	2751 to 3036	19 to 304				286/327 (87 %)	5 diff (98.5 %id)
CU455114	epidermis	.q-u	2751 to 3036	19 to 304				286/357 (80 %)	5 diff (98.6 %id)
TI_149278539		.q-u	2758 to 3456	760 to 62		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	699/700 (99 %)	1 diff (99.9 %id)
BU678509	lung, Primary Lung Epithelial Cells	.q-u	2778 to 3456	697 to 19		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	679/679 (100 %)	1 diff (99.9 %id)
BE693576	breast	.q-u	2811 to 3175	1 to 364				364/364 (100 %)	6 diff (98.4 %id)
AW361308	colon	.q-u	2818 to 3175	11 to 368				358/368 (97 %)	6 diff (98.4 %id)
BQ347672	head_neck	.q-u	2821 to 3185	19 to 388				370/394 (93 %)	7 diff (98.3 %id)
AW361346	colon	.q-u	2829 to 3111	283 to 1				283/283 (100 %)	14 diff (95.1 %id)
AW368549	head_neck	.q-u	2829 to 3175	347 to 1				347/347 (100 %)	5 diff (98.6 %id)
AW368583	head_neck	.q-u	2829 to 3185	363 to 4				360/363 (99 %)	0 diff (100 %id)
AW377759	head_neck	.q-u	2829 to 3112	1 to 284				284/284 (100 %)	1 diff (99.7 %id)
AW854377	colon	.q-u	2829 to 3185	367 to 11				357/367 (97 %)	0 diff (100 %id)
CB157786	Liver	.q-u	2830 to 3035	206 to 1			Submitted on the opposite strand	206/206 (100 %)	0 diff (100 %id)
BM984857	lung	.q-u	2841 to 3456	634 to 19		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	616/616 (100 %)	0 diff (100 %id)
BE927263	colon	.q-u	2842 to 3175	1 to 334				334/334 (100 %)	13 diff (96.2 %id)
AW368598	head_neck	.q-u	2848 to 3190	1 to 346				346/349 (99 %)	11 diff (96.9 %id)
CA445398	Chondrosarcoma, Left Pubic Bone	.q-u	2848 to 3462	634 to 19		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	616/616 (100 %)	1 diff (99.9 %id)
CA413260	Chondrosarcoma Grade II, Left Pelvis	.q-u	2849 to 3456	626 to 19		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	608/608 (100 %)	0 diff (100 %id)
BQ771950	Chondrosarcoma Grade II, Left Pelvis	.q-u	2849 to 3456	626 to 19		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	608/608 (100 %)	0 diff (100 %id)
AW368597	head_neck	.q-u	2851 to 3175	1 to 325				325/325 (100 %)	7 diff (97.9 %id)
BM694132	eye, RPE and Choroid	.q-u	2851 to 3210	1 to 360		fully sequenced,	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	360/360 (100 %)	0 diff (100 %id)
BQ026242	placenta	.q-u	2854 to 3456	621 to 19		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	603/603 (100 %)	0 diff (100 %id)
CK825764	Pancreas, Purified pancreatic islet	.q-u	2857 to 3446	590 to 1				590/590 (100 %)	0 diff (100 %id)
BU626281	Bone, Subchondral Bone	.q-u	2865 to 3456	611 to 19		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	593/593 (100 %)	1 diff (99.9 %id)
AA889334		.q-u	2873 to 3403	530 to 1				530/530 (100 %)	8 diff (98.5 %id)
AA522888	lung, lung tumor	.q-u	2875 to 3455	582 to 1				582/582 (100 %)	6 diff (99.0 %id)
AW361350	colon	.q-u	2877 to 3175	1 to 299				299/299 (100 %)	10 diff (96.7 %id)
CD370031	Alveolar Macrophage, lung	.q-u	2882 to 3456	593 to 19		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	575/575 (100 %)	0 diff (100 %id)
AI924760	lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic)	.q-u	2886 to 3455	570 to 1				570/570 (100 %)	2 diff (99.7 %id)
N98612	senescent fibroblast	.q-u	2897 to 3457	573 to 8				566/573 (98 %)	0 diff (100 %id)
BF349706	head_neck	.q-u	2899 to 3168	277 to 8				270/277 (97 %)	0 diff (100 %id)
CB054285	brain, glioblastoma (pooled)	.q-u	2903 to 3456	604 to 51		fully sequenced, AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	554/554 (100 %)	3 diff (99.5 %id)
CV415637	colon	.q-u	2909 to 3114	1 to 212				212/214 (99 %)	16 diff (92.6 %id)
TI_57234691		.q-u	2914 to 3430	33 to 552				520/715 (72 %)	7 diff (99.1 %id)
BI908846	leukocyte	.q-u	2915 to 3430	1 to 519				519/602 (86 %)	7 diff (98.9 %id)
AW361329	colon	.q-u	2917 to 3185	1 to 270				270/276 (97 %)	10 diff (96.4 %id)
AW377755	head_neck	.q-u	2919 to 3183	268 to 4				265/268 (98 %)	0 diff (100 %id)
AW166134	brain, medulloblastoma	.q-u	2926 to 3457	533 to 2				532/533 (99 %)	0 diff (100 %id)
BU754477	placenta	.q-u	2931 to 3456	544 to 19		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	526/526 (100 %)	0 diff (100 %id)
BF743341	breast	.q-u	2946 to 3385	441 to 2			Submitted on the opposite strand	440/441 (99 %)	0 diff (100 %id)
BM677061	eye, fetal eye	.q-u	2961 to 3456	514 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	496/496 (100 %)	1 diff (99.8 %id)
W20007	parathyroid gland, parathyroid tumor	.q-u	2962 to 3286	1 to 338		fully sequenced,		338/338 (100 %)	11 diff (96.8 %id)
AW974006		.q-u	2966 to 3455	489 to 1			Submitted on the opposite strand	489/489 (100 %)	3 diff (99.4 %id)
BQ269509	Pancreas, Purified pancreatic islet	.q-u	2968 to 3454	514 to 28			Submitted on the opposite strand	487/514 (94 %)	0 diff (100 %id)
AW753308	colon	.q-u	2971 to 3185	1 to 217				217/220 (98 %)	12 diff (94.6 %id)
AA243662	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.q-u	2973 to 3400	427 to 1		fully sequenced,		427/427 (100 %)	6 diff (98.6 %id)
BU738195	eye, lens	.q-u	2976 to 3463	506 to 19	exact	fully sequenced, AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	488/488 (100 %)	0 diff (100 %id)
AI814414	lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic)	.q-u	2986 to 3456	481 to 11		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	471/471 (100 %)	1 diff (99.8 %id)
BF434147	fibrotheoma, ovary	.q-u	2993 to 3423	431 to 1				431/431 (100 %)	9 diff (98.0 %id)
BM801120	embryonal carcinoma, cell line, testis	.q-u	2993 to 3456	496 to 33		available from MGC, AAA	Submitted on the opposite strand	464/1110 (41 %)	3 diff (99.8 %id)
AA834124	Kidney, kidney tumor	.q-u	2995 to 3457	463 to 2				462/463 (99 %)	0 diff (100 %id)
AA700524	parathyroid gland, parathyroid tumor	.q-u	2996 to 3457	465 to 6				460/465 (98 %)	0 diff (100 %id)
AA609418		.q-u	2996 to 3457	464 to 3				462/464 (99 %)	0 diff (100 %id)
AA827220	germinal center B cell	.q-u	2996 to 3455	467 to 11		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	457/457 (100 %)	9 diff (98.1 %id)
AW517683	moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus	.q-u	2996 to 3456	472 to 12		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	461/461 (100 %)	0 diff (100 %id)
CB145961	Liver	.q-u	2996 to 3456	484 to 24		AAA	Submitted on the opposite strand	461/461 (100 %)	6 diff (98.7 %id)
AW629299	pooled	.q-u	2997 to 3457	463 to 3				461/463 (99 %)	0 diff (100 %id)
AA837159	germinal center B cell	.q-u	2999 to 3455	466 to 11		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	456/456 (100 %)	6 diff (98.7 %id)
AI168665	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.q-u	3002 to 3457	456 to 4				453/456 (99 %)	0 diff (100 %id)
AA833958	Kidney, kidney tumor	.q-u	3004 to 3457	455 to 3				453/455 (99 %)	0 diff (100 %id)
AI277615	placenta	.q-u	3008 to 3464	463 to 7	exact	tiling clone,		457/463 (98 %)	0 diff (100 %id)
AI926689	poorly differentiated adenocarcinoma withsignet ring cell features, stomach	.q-u	3008 to 3457	450 to 1				450/450 (100 %)	0 diff (100 %id)
AI803502	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.q-u	3009 to 3456	462 to 15		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	448/448 (100 %)	1 diff (99.8 %id)
AW368577	head_neck	.q-u	3016 to 3185	185 to 11				175/185 (94 %)	0 diff (100 %id)
AI421404	brain, glioblastoma (pooled)	.q-u	3018 to 3457	441 to 2				440/441 (99 %)	0 diff (100 %id)
AI139008		.q-u	3019 to 3457	444 to 8				437/444 (98 %)	0 diff (100 %id)
BM670891	eye, lens	.q-u	3032 to 3456	443 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	425/425 (100 %)	1 diff (99.8 %id)
AW166510	cervix	.q-u	3037 to 3457	423 to 3				421/423 (99 %)	0 diff (100 %id)
BM673123	eye, optic nerve	.q-u	3043 to 3456	432 to 19		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	414/414 (100 %)	0 diff (100 %id)
AI183341	heart	.q-u	3044 to 3456	413 to 1				413/413 (100 %)	0 diff (100 %id)
AW080392	esophagus, squamous cell carcinoma	.q-u	3045 to 3456	412 to 1				412/412 (100 %)	0 diff (100 %id)
AA694170	liver and spleen	.q-u	3046 to 3456	410 to 1				410/410 (100 %)	3 diff (99.3 %id)
AA459261	germinal center B cell	.q-u	3047 to 3455	410 to 2		fully sequenced,		409/410 (99 %)	0 diff (100 %id)
BQ022772	placenta	.q-u	3052 to 3456	423 to 19		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	405/405 (100 %)	0 diff (100 %id)
AI285658	esophagus, squamous cell carcinoma	.q-u	3058 to 3456	399 to 1				399/399 (100 %)	0 diff (100 %id)
AW572638	lymph node, lymphoma, follicular mixed small and largecell	.q-u	3061 to 3450	390 to 1				390/390 (100 %)	0 diff (100 %id)
BE857367	brain, glioblastoma (pooled)	.q-u	3074 to 3454	410 to 30		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	381/381 (100 %)	4 diff (99.0 %id)
AA463705	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.q-u	3079 to 3456	377 to 1				377/377 (100 %)	2 diff (99.5 %id)
BF940604	fibrotheoma, ovary	.q-u	3086 to 3454	381 to 13		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	369/369 (100 %)	0 diff (100 %id)
T79627	liver and spleen	.q-u	3087 to 3457	380 to 2				379/400 (94 %)	0 diff (100 %id)
N68044	cochlea, ear	.q-u	3089 to 3456	373 to 1				373/417 (89 %)	12 diff (97.2 %id)
AI022189	liver and spleen	.q-u	3091 to 3457	368 to 2				367/368 (99 %)	0 diff (100 %id)
AI218147	pooled	.q-u	3091 to 3456	382 to 17		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	366/366 (100 %)	0 diff (100 %id)
BQ022170	placenta	.q-u	3095 to 3456	379 to 18		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	362/362 (100 %)	1 diff (99.8 %id)
AI042467	senescent fibroblast	.q-u	3100 to 3457	364 to 7				358/364 (98 %)	0 diff (100 %id)
AA256294	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.q-u	3102 to 3456	355 to 1				355/355 (100 %)	5 diff (98.6 %id)
BQ013992	Chondrosarcoma, Left Pubic Bone, Lung, chondrosarcoma lung metastasis	.q-u	3103 to 3456	372 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	354/354 (100 %)	0 diff (100 %id)
BQ304505	breast	.q-u	3109 to 3212	106 to 3				104/106 (98 %)	0 diff (100 %id)
AI138996		.q-u	3110 to 3457	350 to 3				348/350 (99 %)	0 diff (100 %id)
H00982	placenta	.q-u	3112 to 3428	331 to 1				331/385 (85 %)	17 diff (95.6 %id)
AI375976		.q-u	3112 to 3464	359 to 7	exact			353/359 (98 %)	0 diff (100 %id)
AW183567	pooled	.q-u	3115 to 3457	347 to 5				343/347 (98 %)	0 diff (100 %id)
AI140576	liver and spleen	.q-u	3121 to 3456	335 to 1				335/335 (100 %)	5 diff (98.6 %id)
AA779576		.q-u	3132 to 3464	338 to 7	P39R G40A R41G P42L V43C ...			332/348 (95 %)	0 diff (100 %id)
AI381413		.q-u	3135 to 3457	328 to 5				324/328 (98 %)	0 diff (100 %id)
AA878685	2 pooled tumors (clear cell type), Kidney	.q-u	3140 to 3400	265 to 5				261/265 (98 %)	0 diff (100 %id)
BQ304504	breast	.q-u	3145 to 3300	159 to 3				157/159 (98 %)	0 diff (100 %id)
AI092382	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.q-u	3152 to 3456	303 to 1				303/303 (100 %)	2 diff (99.4 %id)
AA813029		.q-u	3153 to 3457	306 to 3				304/306 (99 %)	0 diff (100 %id)
AA987855	Kidney, kidney tumor	.q-u	3153 to 3464	312 to 2	R35W V37X R38A P39R G40A ...			311/312 (99 %)	0 diff (100 %id)
BU732310	eye, RPE and Choroid	.q-u	3180 to 3456	295 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	277/277 (100 %)	0 diff (100 %id)
AI702339	adenocarcinoma, Pancreas	.q-u	3201 to 3457	259 to 1				259/259 (100 %)	2 diff (99.3 %id)
AI392789	B-cell, chronic lymphotic leukemia	.q-u	3216 to 3463	248 to 1				248/248 (100 %)	0 diff (100 %id)
N91348	parathyroid gland, parathyroid tumor	.q-u	3256 to 3456	201 to 1		fully sequenced,		201/201 (100 %)	3 diff (98.6 %id)
AA558929	breast	.q-u	3257 to 3456	210 to 11		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	200/200 (100 %)	5 diff (97.5 %id)
AA557439	low-grade prostatic neoplasia, Prostate	.q-u	3263 to 3447	205 to 21		AAA		185/194 (95 %)	0 diff (100 %id)
AA770052	liver and spleen	.q-u	3269 to 3457	190 to 2				189/190 (99 %)	0 diff (100 %id)
AW073159	brain, glioblastoma (pooled)	.q-u	3269 to 3454	194 to 9				186/194 (95 %)	0 diff (100 %id)
FN116260	breast carcinoma	.q-u	3271 to 3381	1 to 112				112/112 (100 %)	3 diff (97.4 %id)
AI699717	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.q-u	3290 to 3456	167 to 1				167/167 (100 %)	1 diff (99.5 %id)
AA884336	pooled	.q-u	3330 to 3456	143 to 17		AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	127/127 (100 %)	0 diff (100 %id)
AA470400	colon	.q-u	3339 to 3428	89 to 1				89/89 (100 %)	2 diff (97.8 %id)
AI193808	lung	.q-u	3358 to 3455	98 to 1				98/98 (100 %)	1 diff (99.0 %id)
AA705996	parathyroid gland, parathyroid tumor	.q-u	3377 to 3457	86 to 6				81/86 (94 %)	0 diff (100 %id)
BU852158	testis	.r-u	1 to 530	1 to 530		tiling clone,		530/533 (99 %)	3 diff (99.5 %id)
BG402127	Kidney	.r-u	109 to 817	1 to 702		tiling clone,		702/863 (81 %)	20 diff (97.7 %id)
BG565705	Liver	.r-u	367 to 1022	1 to 662		tiling clone,		662/667 (99 %)	11 diff (98.4 %id)
BE048512	Kidney	.r-u	525 to 941	424 to 7		tiling clone,		418/424 (98 %)	0 diff (100 %id)
AL601395		.r-u	926 to 1402	1 to 485		tiling clone, AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	485/485 (100 %)	5 diff (99.0 %id)
DN919447		.r-u	1348 to 1969	1 to 618		tiling clone,		618/619 (99 %)	9 diff (98.6 %id)
CR611364	fetal brain	.s-u	1 to 1218	1 to 1218	exact	tiling clone,		1218/1218 (100 %)	0 diff (100 %id)
AL538879	brain, fetal brain	.s-u	1 to 869	1 to 869	C2X S44T H45L C46X A47L ...			869/869 (100 %)	14 diff (98.4 %id)
N25507	melanocyte	.s-u	252 to 596	87 to 435				349/438 (79 %)	10 diff (97.8 %id)
AL567538	brain, fetal brain	.s-u	267 to 1171	907 to 1				907/907 (100 %)	9 diff (99.1 %id)
CV381271	uterus_tumor	.s-u	275 to 619	78 to 414				337/414 (81 %)	6 diff (98.6 %id)
BX451679	brain, fetal brain	.s-u	740 to 1218	1 to 478				478/478 (100 %)	2 diff (99.6 %id)
H29210	whole brain	.t-u	1 to 477	1 to 479	E67D L68*	tiling clone,		479/479 (100 %)	4 diff (99.2 %id)
BX094198	whole brain	.t-u	492 to 1052	563 to 1		tiling clone,	Submitted on the opposite strand	563/563 (100 %)	3 diff (99.5 %id)
CA395789	eye, RPE/choroid	.t-u	502 to 1086	1 to 585		tiling clone,		585/585 (100 %)	1 diff (99.9 %id)
H29211	whole brain	.t-u	550 to 1047	500 to 1				500/505 (99 %)	14 diff (97.3 %id)
AA701532	liver and spleen	.t-u	568 to 1038	471 to 1				471/471 (100 %)	1 diff (99.8 %id)
AA348684	brain, hippocampus	.t-u	735 to 1038	304 to 1			Submitted on the opposite strand	304/304 (100 %)	1 diff (99.7 %id)
DA713959		.u	1 to 567	2 to 569	exact	tiling clone, capped		568/568 (100 %)	1 diff (99.9 %id)
DB216945	trachea	.va-u	1 to 554	2 to 554	R9K T11L L12*	tiling clone, capped		553/553 (100 %)	1 diff (99.9 %id)
AA174136. matches multiple genes		.vb-u	1 to 542	540 to 1	exact	tiling clone,	also hits gene gladoyby	540/540 (100 %)	18 diff (96.7 %id)
DB217745	trachea	.vc-u	1 to 489	2 to 490	exact	tiling clone, capped		489/489 (100 %)	1 diff (99.8 %id)
DW443012	Liver	.vd	1 to 179	6 to 184	exact	tiling clone, AAA	Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base)	179/184 (97 %)	6 diff (96.8 %id)
FN054843	breast carcinoma	.ve-u	1 to 67	1 to 67	D9G	tiling clone,		67/67 (100 %)	2 diff (97.1 %id)
AV702381	adrenal gland	Gene USP40, variant not shown					Suspected internal deletion, this clone was ignored
AK297821	heart	Gene USP40, variant not shown					This clone was ignored
CU442889	epidermis	Gene USP40, variant not shown					This clone was ignored
CU444681	epidermis	Gene USP40, variant not shown					This clone was ignored
CU445693	epidermis	Gene USP40, variant not shown					This clone was ignored
CU449001	epidermis	Gene USP40, variant not shown					This clone was ignored
CU449722	epidermis	Gene USP40, variant not shown					This clone was ignored
CU453104	epidermis	Gene USP40, variant not shown					This clone was ignored
T58221	fetal spleen, Spleen	Gene USP40, variant not shown					This clone was ignored
AA043738	uterus	Gene USP40, variant not shown					Suspected internal deletion, this clone was ignored
AA043739	uterus	Gene USP40, variant not shown					Suspected internal deletion, this clone was ignored
BC067300	testis	Gene USP40, variant not shown				available from MGC, AAA	Suspected internal deletion, this clone was ignored
TI_154120403		Gene USP40, variant not shown				AAA	Suspected internal deletion, this clone was ignored